Literature DB >> 19656642

Altered affective response in marijuana smokers: an FMRI study.

Staci A Gruber1, Jadwiga Rogowska, Deborah A Yurgelun-Todd.   

Abstract

More than 94 million Americans have tried marijuana, and it remains the most widely used illicit drug in the nation. Investigations of the cognitive effects of marijuana report alterations in brain function during tasks requiring executive control, including inhibition and decision-making. Endogenous cannabinoids regulate a variety of emotional responses, including anxiety, mood control, and aggression; nevertheless, little is known about smokers' responses to affective stimuli. The anterior cingulate and amygdala play key roles in the inhibition of impulsive behavior and affective regulation, and studies using PET and fMRI have demonstrated changes within these regions in marijuana smokers. Given alterations in mood and perception often observed in smokers, we hypothesized altered fMRI patterns of response in 15 chronic heavy marijuana smokers relative to 15 non-marijuana smoking control subjects during the viewing of masked happy and fearful faces. Despite no between-group differences on clinical or demographic measures, smokers demonstrated a relative decrease in both anterior cingulate and amygdalar activity during masked affective stimuli compared to controls, who showed relative increases in activation within these regions during the viewing of masked faces. Findings indicate that chronic heavy marijuana smokers demonstrate altered activation of frontal and limbic systems while viewing masked faces, consistent with autoradiographic studies reporting high CB-1 receptor density in these regions. These data suggest differences in affective processing in chronic smokers, even when stimuli are presented below the level of conscious processing, and underscore the likelihood that marijuana smokers process emotional information differently from those who do not smoke, which may result in negative consequences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656642      PMCID: PMC2752701          DOI: 10.1016/j.drugalcdep.2009.06.019

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  48 in total

1.  Dextroamphetamine modulates the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Francesco Fera; William G Smith; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

Review 2.  Being stoned: a review of self-reported cannabis effects.

Authors:  Bob Green; David Kavanagh; Ross Young
Journal:  Drug Alcohol Rev       Date:  2003-12

3.  Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.

Authors:  Katerina Zavitsanou; Therese Garrick; Xu Feng Huang
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-03       Impact factor: 5.067

4.  Activation of the amygdala and anterior cingulate during nonconscious processing of sad versus happy faces.

Authors:  William D S Killgore; Deborah A Yurgelun-Todd
Journal:  Neuroimage       Date:  2004-04       Impact factor: 6.556

5.  Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims.

Authors:  B L Hungund; K Y Vinod; S A Kassir; B S Basavarajappa; R Yalamanchili; T B Cooper; J J Mann; V Arango
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

6.  Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography.

Authors:  Roy J Mathew; William H Wilson; Timothy G Turkington; Thomas C Hawk; R Edward Coleman; Timothy R DeGrado; James Provenzale
Journal:  Psychiatry Res       Date:  2002-12-30       Impact factor: 3.222

7.  Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.

Authors:  Carl L Hart; Amie S Ward; Margaret Haney; Sandra D Comer; Richard W Foltin; Marian W Fischman
Journal:  Psychopharmacology (Berl)       Date:  2002-09-14       Impact factor: 4.530

8.  Effects of THC on behavioral measures of impulsivity in humans.

Authors:  Jennifer McDonald; Laura Schleifer; Jerry B Richards; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2003-04-30       Impact factor: 7.853

9.  Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.

Authors:  S R Wachtel; M A ElSohly; S A Ross; J Ambre; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  2002-04-19       Impact factor: 4.530

10.  Cannabinoid modulation of amygdala reactivity to social signals of threat in humans.

Authors:  K Luan Phan; Mike Angstadt; Jamie Golden; Ikechukwu Onyewuenyi; Ana Popovska; Harriet de Wit
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

View more
  76 in total

1.  Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect.

Authors:  Christine A Rabinak; Chandra Sekhar Sripada; Mike Angstadt; Harriet de Wit; K Luan Phan
Journal:  J Neural Transm (Vienna)       Date:  2011-12-11       Impact factor: 3.575

2.  Abnormal medial prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation.

Authors:  Michael J Wesley; Joshua A Lile; Colleen A Hanlon; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2015-12-22       Impact factor: 4.530

Review 3.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

Review 4.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

Review 5.  Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

6.  Balanced modulation of striatal activation from D2 /D3 receptors in caudate and ventral striatum: Disruption in cannabis abusers.

Authors:  Dardo Tomasi; Gene-Jack Wang; Nora D Volkow
Journal:  Hum Brain Mapp       Date:  2015-06-09       Impact factor: 5.038

7.  Blunted stress reactivity in chronic cannabis users.

Authors:  Carrie Cuttler; Alexander Spradlin; Amy T Nusbaum; Paul Whitney; John M Hinson; Ryan J McLaughlin
Journal:  Psychopharmacology (Berl)       Date:  2017-05-31       Impact factor: 4.530

8.  Emotion regulation deficits in regular marijuana users.

Authors:  Kaeli Zimmermann; Christina Walz; Raissa T Derckx; Keith M Kendrick; Bernd Weber; Bruce Dore; Kevin N Ochsner; René Hurlemann; Benjamin Becker
Journal:  Hum Brain Mapp       Date:  2017-05-31       Impact factor: 5.038

9.  Alcohol use disorder and cannabis use disorder symptomatology in adolescents are differentially related to dysfunction in brain regions supporting face processing.

Authors:  Emily K Leiker; Harma Meffert; Laura C Thornton; Brittany K Taylor; Joseph Aloi; Heba Abdel-Rahim; Niraj Shah; Patrick M Tyler; Stuart F White; Karina S Blair; Francesca Filbey; Kayla Pope; Matthew Dobbertin; R James R Blair
Journal:  Psychiatry Res Neuroimaging       Date:  2019-09-12       Impact factor: 2.376

10.  γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers.

Authors:  Andrew P Prescot; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Drug Alcohol Depend       Date:  2013-03-21       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.